🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the ocular comfort and safety of olo...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01326858
The purpose of this study was to assess the safety and efficacy of AL-4943A...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01479374
The purpose of this study is to demonstrate that Olopatadine 0.2% is superi...
Status
Completed
Location
Multiple Locations
Start Date
2006-04-18
Trial ID
NCT00331500
The purpose of the study is to demonstrate safety and efficacy of Olopatadi...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00987272
The purpose of this study is to evaluate olopatadine 0.2% QD (once per day)...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02322216
This study will evaluate the safety and efficacy of AGN-229666 for the prev...
Status
Completed
Location
Multiple Locations
Start Date
2014-06-04
Trial ID
NCT02161146
Treatments Being Tested
The purpose of this study is to evaluate an ophthalmic solution for the tre...
Status
Completed
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01743027